Skip to main content

Detection of antiperinuclear factor and antikeratin antibodies

  • Chapter
Manual of Biological Markers of Disease
  • 66 Accesses

Abstract

The diagnosis of rheumatoid arthritis (RA) is initially based on clinical manifestations. Serological support for such a diagnosis is not very well established and depends mainly on the presence of rheumatoid factors (RF). A positive RF test has a predictive value [1] and is related to disease with a more severe outcome [2]. However, RF is also present in other (autoimmune) diseases and in control sera from healthy people [3]. Therefore, testing for a second RA-specific antibody is very useful, especially for the management of seronegative RA patients. Both the antiperinuclear factor (APF) (reviewed in [4]) and antikeratin antibodies (AKA) (reviewed in [4] and [5]) are helpful in this respect.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Abbreviations

APF:

antiperinuclear factor

AKA:

antikeratin antibody

RA:

rheumatoid arthritis

RF:

rheumatoid factor

WHO:

World Health Organization

References

  1. Valkenburg HA, Ball J, Burch TA et al.(1966) Rheumatoid factors in a rural population. Ann Rheum Dis 25: 497–508

    PubMed  CAS  Google Scholar 

  2. Kellgren JH, O’Brien WH (1962) On the natural history of rheumatoid arthritis in relation to sheep cell agglutination test (SCAT). Arthr Rheum 5: 115

    Google Scholar 

  3. Waller MV, Toone EC, Vaughan E (1964) Study of rheumatoid factor in a normal population. Arthr Rheum 7: 513–520

    Article  CAS  Google Scholar 

  4. Hoet RMA, van Venrooij WJ (1992) The antiperinuclear factor (APF) and antikeratin antibodies (AKA) in rheumatoid arthritis. In Smolen JS, Kalden JR, Maini RN (Eds) Rheumatoid Arthritis, Recent Research Advances (pp. 299–327). Springer Verlag Berlin Heidelberg New York

    Chapter  Google Scholar 

  5. Vincent C, Serre G, Lapeyre F, Fournié B, Ayrolles C, Fournié A, Soleilhavoup J-P (1989) High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called “antikeratin antibodies”. Ann Rheum Dis 48: 712–722

    Article  PubMed  CAS  Google Scholar 

  6. Nienhuis RLF, Mandema E (1964) A new serum factor in patients with rheumatoid arthritis. The antiperinuclear factor. Ann Rheum Dis 23: 302–305

    Article  PubMed  CAS  Google Scholar 

  7. Smit JW, Sondag-Tschroots IRJM, Aaij C, Feltkamp TEW, Feltkamp-Vroom TM (1980) The antiperinuclear factor. II. A light-microscopical and immunofluorescence study on the antigenic substrate. Ann Rheum Dis 39: 381–386

    Article  PubMed  CAS  Google Scholar 

  8. Hoet RMA, Arends M, Boerbooms AMTh, Ruiter DJ, van Venrooij WJ (1991) Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis. Colocalisation of the perinuclear factor and profilaggrin. Ann Rheum Dis 50: 611–619

    Article  PubMed  CAS  Google Scholar 

  9. Visconti A, Cava L, Fontana G (1964) Ricerca del fattore anti-perinucleare (APF) nell’ artrite reumatoide ed in altre malattie. Osp Magg 59: 1357

    CAS  Google Scholar 

  10. Marmont AM, Damasio EE, Bertorello C, Rossi F (1967) Studies on the antiperinuclear factor. Arthr Rheum 10: 117–128

    Article  CAS  Google Scholar 

  11. Roques MT (1969) Les anticorps dits périnucléaires. Thesis, Paris

    Google Scholar 

  12. Sondag-Tschroots IRJM, Aaij C, Smit JW, Feltkamp TEW (1979) The antiperinuclear factor. 1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. Ann Rheum Dis 38: 248–251

    Article  PubMed  CAS  Google Scholar 

  13. Johnson GD, Carvalho A, Holborow EJ, Goddard DH, Russell G (1981) Antiperinuclear factor and antikeratin antibodies in rheumatoid arthritis. Ann Rheum Dis 40: 263–266

    Article  PubMed  CAS  Google Scholar 

  14. Cassani F, Ferri S, Bianchi FB, Zauli D, Pisi E (1983) Antiperinuclear factor in an Italian series of patients with rheumatoid arthritis. Ric Clin Lab 13: 347–352

    PubMed  CAS  Google Scholar 

  15. Youinou P, Le Goff P, Miossec P (1983) Untersuchungen zur beziehung zwischen antiperinucleären factoren, anti-keratin-antikörpern und dem agglutinierenden und nicht agglutinierenden rheumafactor bei der chronischen polyarthritis. Z Rheumatol 42: 36–39

    PubMed  CAS  Google Scholar 

  16. Kataaha PK, Mortazavi-Milani SM, Russel G, Holborow EJ (1985) Anti-intermediate filament antibodies, antikeratin antibody, and antiperinuclear factor in rheumatoid arthritis and infectious mononucleosis. Ann Rheum Dis 44: 446–449

    Article  PubMed  CAS  Google Scholar 

  17. Westgeest AAA, Boerbooms AMTh, Jongmans M, Vandenbroucke JP, Vierwinden G, van de Putte LBA (1987) Antiperinuclear factor: Indicator of more severe disease in seronegative rheumatoid arthritis. J Rheumatol 14: 893–897

    PubMed  CAS  Google Scholar 

  18. Janssens X, Veys EM, Verbruggen G, Declercq L (1988) The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. J Rheumatol 15: 1346–1350

    PubMed  CAS  Google Scholar 

  19. Vivino FB, Maul GG (1990) Histologic and electron microscopic characterization of the perinuclear factor antigen. Arthr Rheum 33: 960–969

    Article  CAS  Google Scholar 

  20. Young BJJ, Mallya RK, Leslie RDG, Clark CJM, Hamblin TJ (1979) Anti-keratin antibodies in rheumatoid arthritis. Br Med J ii: 97–99

    Article  Google Scholar 

  21. Scott DL, Delamere JP, Jones LJ, Walton KW (1981) Significance of laminar antikeratin antibodies to rat oesophagus in rheumatoid arthritis. Ann Rheum Dis 40: 267–271

    Article  PubMed  CAS  Google Scholar 

  22. Ordeig J, Guardia J (1984) Diagnostic value of antikeratin antibodies in rheumatoid arthritis. J Rheumatol 11: 602–604

    PubMed  CAS  Google Scholar 

  23. Hajiroussou VJ, Skingle J, Gillett AP, Webley M (1985) Significance of antikeratin antibodies in rheumatoid arthritis. J Rheumatol 12: 57–59

    PubMed  CAS  Google Scholar 

  24. Mallya RK, Young BJJ, Pepys MB, Hamblin TJ, Mace BEW, Hamilton EBD (1983) Anti-keratin antibodies in rheumatoid arthritis: frequency and correlation with other features of the disease. Clin Exp Immunol 51: 17–20

    PubMed  CAS  Google Scholar 

  25. Kirnstein H, Mathiesen FK (1987) Antikeratin antibodies in rheumatoid arthritis. Scand J Rheumatology 16: 331–337

    Article  Google Scholar 

  26. Youinou P, Le Goff P, Colaco CB, Thivolet J, Tater D, Viac J, Shipley M (1985) Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases. Ann Rheum Dis 44: 450–454

    Article  PubMed  CAS  Google Scholar 

  27. Meyer O, Fabregas D, Cyna L, Ryckewaert A (1986) Les anticorps anti-kératine. Un marqueur des polyarthrites rhumatoïdes évolutives. Rev Rhum Mal Osteoartic 53: 601–605

    PubMed  CAS  Google Scholar 

  28. Quismorio PF, Kaufman RL, Beardmore T, Mongan ES (1983) Reactivity of serum antibodies to the keratin layer of rat esophagus in patients with rheumatoid arthritis. Arthritis Rheum 26: 494–499

    Article  PubMed  Google Scholar 

  29. Paimela L, Gripenberg M, Kurki P, Leirisalo-Repo M (1992) Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis 51: 743–746

    Article  PubMed  CAS  Google Scholar 

  30. Miossec P, Youinou P, Le Goff P, Moineau MP (1982) Clinical relevance of antikeratin antibodies in rheumatoid arthritis. Clin Rheumatol 1: 185–189

    Article  PubMed  CAS  Google Scholar 

  31. Anderson SAG, Bentzon MW, Houba V, Krag P (1970) International reference preparation of rheumatoid arthritis serum. Bull. Wld Hlth Org 42: 311–318

    CAS  Google Scholar 

  32. Westgeest AAA, Boerbooms AMTh, van de Putte LBA (1990) The influence of serumdilution on finding of antiperinuclear factor prevalence in rheumatoid arthritis. Arthr Rheum 33: 759–760

    Article  CAS  Google Scholar 

  33. Feltkamp TEW, Boerbooms AMTh, De Keyser F, Dumais M, Hoet RM, van Venrooij WJ, Verbruggen G, Veys EM, Youinou P (1990) Antiperinuclear factor — standardization program. Clin Rheumatol 9: 112–113

    Article  Google Scholar 

  34. Feltkamp TEW, Boerbooms AMTH, Geertzen HGM, Hoet RMA, De Keyser F, van Venrooij WJ, Verbruggen G, Veys EM, Youinou P (1993) Interlaboratory variability of the antiperinuclear factor (APF) test for rheumatoid arthritis. Clin Rheumatol 11: 57–59

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Hoet, R.M.A. (1993). Detection of antiperinuclear factor and antikeratin antibodies. In: Van Venrooij, W.J., Maini, R.N. (eds) Manual of Biological Markers of Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5444-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-5444-4_10

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-7923-4243-4

  • Online ISBN: 978-94-011-5444-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics